Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
MAGE-A4：Afami-cel和ADP-A2M4CD8|滑膜肉瘤|卵巢癌|TCR|CD8|细胞|患者|肿瘤|治疗|疗法|数据|-健康界
FDA Greenlights First Engineered Cell Therapy for a Solid Tumor ...
Detection of afami-cel and T cell phenotypes in patient tumor ...
FDA Grants Accelerated Approval to Afamitresgene Autoleucel (TECELRA ...
SPEAR T细胞 | afami-cel 为实体瘤患者带来|滑膜肉瘤|细胞|肿瘤|抗原|-健康界
里程碑！全球首款TCR-T细胞疗法申报上市
SPEAR T细胞 | afami-cel 为实体瘤患者带来希望 - 知乎
全球第二款TCR-T疗法ADP-A2M4(Afami-Cel、Afamitresgene Autoleucel)用于治疗滑膜肉瘤有望上市_全球 ...
TCR-T细胞免疫疗法Afami-cel(Tecelra)在美国获批上市,TCR-T细胞治疗实体瘤患者有救了_全球肿瘤医生网
新型TCR-T疗法Afami-cel获FDA优先评审资格_全球肿瘤医生网
The FDA has approved a cellular therapy called afamitresgene autoleucel ...
Novel T cell receptor therapy afami-cel shows early anti-tumor activity ...
读书报告 | Afamitresgene autoleucel治疗晚期滑膜肉瘤和黏液样圆细胞脂肪肉瘤的开放标签2期试验-MedSci.cn
TECELRA® (afami-cel) is the first TCR-T cell therapy for solid tumors ...
FDA Gives Priority Review to Afami-Cel in Advanced Synovial Sarcoma ...
(PDF) Abstract A023: Identifying new therapeutic indications for ...
Nature杂志重磅消息:TCR-T细胞疗法Afami-Cel疾病控制率高达74%,对多种癌症有效_全球肿瘤医生网
Afami-cel: First T-Cell Therapy Approved for Solid Tumors
Optimal Timing for Introducing Afami-Cel Therapy in the Treatment Journey
Afami-cel Demonstrates Enduring Responses in Pretreated Synovial Sarcoma
Adaptimmune Receives U.S. FDA Accelerated Approval of TECELRA ...
Adaptimmune’s Afami-cel is the first FDA-approved T-cell receptor ...
The FDA has approved the first engineered T cell therapy, afami-cel ...
FDA Accepts BLA for Afami-Cel for Priority Review as Treatment of ...
FDA Approves Adaptimmune’s TCR T-cell Therapy Afami-cel for Synovial ...
Abstract A023: Identifying new therapeutic indications for ...
afamitresgene autoleucel (ADP-A2M4) / Adaptimmune
Afamitresgene Autoleucel, First Gene Therapy to Treat Adults With ...
FDA接受Afami-cel治疗晚期滑膜肉瘤的生物制品许可申请，并优先审查-上市-医保-临床适应症-香港济民药业
易前沿 | 全球首款TCR-T疗法Afami-cel滚动上市，滑膜肉瘤将迎来新疗法 - 知乎
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round ...
CTOS 2022: FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE ...
FDA Grants Accelerated Approval for Afami-Cel in Treatment of Advanced ...
FDA Approves First Engineered Cell Therapy for a Solid Tumor FDA ...
Tricuspid Valve Replacement System, Afami-Cel for Synovial Sarcoma ...
Newly Approved Cell Therapy Afami-Cel Shows Long-Term Tumor Control in ...
实体肿瘤针对MAGE-A4抗原的TCR-T细胞治疗,TCR-T细胞疗法ADP-A2M4 T细胞免疫疗法横空出世-无癌家园
Addressing Potential Barriers to the Adoption of Afami-Cel Therapy ...
Afamitresgene Autoleucel Elicits Impressive Responses in Synovial Sarcoma
New Hope On The Horizon For Advanced Synovial Sarcoma | Faculty of Medicine
FDA accepts Adaptimmune’s BLA for afami-cel for synovial sarcoma | The ...
afammi-cel-sarcoma
FDA Grants Accelerated Approval to Afami-Cel for Advanced Synovial Sarcoma
TCR-T细胞疗法治疗实体瘤无瘤生存超9年,成为新一代抗癌利器,预计8月首款产品上市_全球肿瘤医生网
Afami-cel: A new T-cell immunotherapy for synovial sarcoma | Bichoy ...
How Afami-Cel Immunotherapy Helped a Young Man With Stage 4 Synovial ...
潜在首款！Adaptimmune癌症TCR-T细胞疗法afami-cel关键试验结果登《柳叶刀》
FDA approves engineered cell therapy for treating rare sarcoma
FDA Approval Insights: Afami-Cel for Pretreated, Unresectable or ...
Adaptimmune Completes Submission of Rolling Biologics License ...
Afami-cel Granted Accelerated Approval for Advanced Synovial Sarcoma
Afamitresgene autoleucel (afami-cel) - News, Articles etc. - European ...
FDA Approves Adaptimmune's Afami-cel Submission for Advanced Synovial ...
Serum cytokine levels pre-and post-afami-cel treatment. | Download ...
SPEARHEAD-1: a single-arm phase 2 trial of afamitresgene autoleucel ...
FDA Grants Afami-cel Accelerated Approval in Advanced Synovial Sarcoma
Afami-cel’s Mechanism of Action and Role in Synovial Sarcoma | Targeted ...
Adaptimmune Reports Better Outcomes for People with Synovial Sarcoma ...
How Adaptimmune's T-Cell Therapy Development Pipeline Became a ...
A Food and Drug Administration (FDA) dos Estados Unidos aprovou o ...
The FDA approval of afami-cel is a powerful reminder of what’s possible ...
Afamitresgene autoleucel in advanced synovial sarcoma and myxoid round ...
Afami-cel Shows Clinical Benefit in Synovial Sarcoma and Myxoid/Round ...
Afami-cel For The Treatment Of Synovial Cancers
Afamitresgene Autoleucel Induces Durable Clinical Response in Advanced ...
Will Adaptimmune's Afami-cel End The Decade-Long Wait In Synovial ...
Afami-cel治疗晚期滑膜肉瘤和黏液样圆细胞脂肪肉瘤的研究效果_海得康海外新特药
New Research Synovial Sarcoma Treatment - Cancer Education and Research ...
Afami-cel对晚期滑膜肉瘤和粘液样圆细胞脂肪肉瘤具有治疗效果_海得康海外新特药
Afami-Cel Shows Durable Persistence and Tumor-Killing Abilities in ...
2023 HLA-A02 MAGE-A4实体瘤的自T细胞治疗|环磷酰胺|实体瘤|CRS|细胞|肿瘤|LD|血清|活检|-健康界
TCR-T细胞疗法Tecelra（afami-cel）治疗滑膜肉瘤的临床数据
Afamitresgene Autoleucel用于治疗晚期滑膜肉瘤_祺昌医药有限公司_香港祺昌大药房
滑膜肉瘤新疗法！TCR-T疗法afami-cel的临床数据及不良反应！-印塔健康官网
New FDA approval for afami-cel gene therapy | Sam Gibbons posted on the ...
Adaptimmune's Afami-cel Receives FDA Accelerated Approval - CTOL ...
2024年有望上市的CAR-T疗法、TIL疗法、TCR-T疗法多款细胞产品,攻克血液肿瘤及实体瘤的号角已吹响-无癌家园
潜在首款！Adaptimune实体瘤TCR-T疗法afami-cel的BLA申请获FDA优先审评资格
FDA Approval of Afamitresgene Autoleucel for Sarcoma May Change Cancer ...
一种新型T细胞疗法：针对MAGE-A4癌抗原过继T细胞受体疗法（afami cel）_吉卡干细胞-创新基因细胞技术转化与一体化精准健康管理服务
New Research Osteosarcoma Treatment - Cancer Education and Research ...
Afami-cel Approval May Open Gateway for Synovial Sarcoma Advancements
New Afami-Cel Data to Support BLA Submission in Synovial Sarcoma
Explanation of the primary mechanism of action of compounds employed in ...
아피셀테라퓨틱스
